1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D3EA9118664A396E85257A7E004D2596
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/D3EA9118664A396E85257A7E004D2596!OpenDocument
18
19OpenDocument
2044.201.72.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Sales and Marketing » Marketing Management » Designing Marketing Strategies » Product Positioning and Differentiation

Document Excerpt: Pfizer’s 180-Day Battle: Branded Lipitor vs. Generics - Maximizing Revenues at the End of a Lifecycle

DB Image

ID: MD-336


Features:

25 Info Graphics

6 Data Graphics

75+ Metrics

6 Narratives


Pages/Slides: 4


Published: Pre-2018


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here.

This excerpt includes research findings and metrics from document #5223 "Pfizer’s 180-Day Battle: Branded Lipitor vs. Generics - Maximizing Revenues at the End of a Lifecycle."

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Pfizer

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.